Reversible AChE inhibitors in C. elegans vs. rats, mice

Area of Science:

• Toxicology
• Neuroscience
• Model Organisms

Background:

• Acetylcholinesterase (AChE) inhibitors are widely used toxicants.
• Vertebrate models for toxicity testing are expensive and time-consuming.
• Caenorhabditis elegans offers a potential alternative for toxicological screening.

Purpose of the Study:

• To evaluate Caenorhabditis elegans as a model organism for vertebrate toxicity screening.
• To compare the toxicity of reversible AChE inhibitors in C. elegans to rats and mice.
• To confirm that the mechanism of toxicity is conserved between C. elegans and mammals.

Main Methods:

• Generated movement-concentration curves for C. elegans exposed to carbamates.
• Determined 50th percentiles for movement and ranked relative potencies.
• Statistically compared C. elegans toxicity rankings with rat and mouse oral acute LD50s.
• Measured AChE activity in response to carbamate exposure.

Main Results:

• C. elegans toxicity rankings showed significant correlation with rat and mouse rankings (alpha=0.05).
• A concentration-dependent decrease in AChE activity correlated with decreased movement in C. elegans.
• AChE inhibition preceded observable movement decrease, mirroring mammalian responses.
• C. elegans demonstrated conserved toxicity mechanisms for carbamate exposure.

Conclusions:

• Caenorhabditis elegans exhibits conserved toxicity mechanisms for AChE inhibitors compared to vertebrates.
• C. elegans serves as a valid and potentially cost-effective model for vertebrate toxicological screening.
• This study supports the use of C. elegans in assessing the toxicological impact of AChE inhibitors.